Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
about
A balancing act: efflux/influx in mycobacterial drug resistanceMethodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other MycobacteriaMechanisms of action of isoniazidComparative analyses of transport proteins encoded within the genomes of Mycobacterium tuberculosis and Mycobacterium lepraeCorrelations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.Detecting novel genetic variants associated with isoniazid-resistant Mycobacterium tuberculosis.Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.An upstream truncation of the furA-katG operon confers high-level isoniazid resistance in a Mycobacterium tuberculosis clinical isolate with no known resistance-associated mutations.Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosisCurrent status and future development of antitubercular chemotherapy.Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin NDiscrimination of single-copy IS6110 DNA fingerprints of Mycobacterium tuberculosis isolates by high-resolution minisatellite-based typing.Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania.Detection of multidrug resistance in Mycobacterium tuberculosisComparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivationResistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis.Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis.Antitubercular pharmacodynamics of phenothiazinesEpidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolatesMycobacterium tuberculosis: drug resistance and future perspectives.Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis.Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia.Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.Drug-susceptibility testing in TB: current status and future prospects.Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons.Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis.High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore.Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2).Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades.
P2860
Q24644870-C80CD552-0784-4735-8AFE-310F13033041Q28389409-F0BD939F-9645-47AC-B715-F44387508132Q29026436-2B6BAE22-C208-4EF9-87E2-2FC99A8F5D9EQ30410820-66C28AFE-E93F-4E03-B7D8-48C460B7755AQ33410693-914A99A6-A55C-4F54-B436-92B78FC772B6Q33582771-B82987FE-3A41-4136-8909-6BEC1BAE0F51Q33858360-021BCBD0-0E65-4FC9-B462-755F795CF102Q33905492-B53010B8-60B3-468D-B08F-8B1128FB2BFBQ34041549-A3B1F07F-1923-4BA5-80DB-B77C0FB06150Q34143763-2D12DA92-E51D-4518-A2A6-6D064C0AB702Q34299052-48B9BA5D-ACA8-4BAC-8B52-5970184C623FQ34410451-AE271448-7BD7-42D8-9B3B-40573F64A33BQ34483621-5F54E99A-97C1-450D-AA19-B7265C53EC6BQ34768541-8954606E-7768-4FCC-B362-CE58996EF224Q34924586-58ECF6B9-ED11-4A41-AA5F-9A08F070F986Q34943381-44871377-6F7A-42F6-8352-5AEA77C569A7Q34973711-857433CD-644B-4553-B7F0-552E325FE070Q35014210-97952EE2-9994-406F-9C58-50C831CEBFEFQ35690316-97552889-BFD1-4110-B14B-4DF2CC527518Q35769769-11CEE1F9-BB44-4D7C-830E-90D5518A4346Q35917534-6D88397C-8980-4B20-B413-CBD49476BCC0Q35922173-1F2FC152-8B33-4906-90BB-97229EBD988AQ36675149-900E4D29-0E73-490E-9E47-3DBBFA594279Q37036449-B80A097E-861E-445B-B85B-E15CD742882AQ37333132-06B9A299-AE88-4E81-894E-564C17C72780Q37506524-7BBA6A12-A6FD-4C77-9D0D-E3C0B054C63CQ39563402-FDF3D5E1-5A2E-4BC6-A1E3-C638FFDCB280Q39606450-7C6299BB-D878-43B8-BBAD-3263159B5BC4Q39665051-DFEC7E22-620E-483F-AE0B-6DE9646950A5Q39743333-38FF96D2-BA4D-4712-AE84-7CE5ED0888C6Q39872573-BE2E839E-9AFB-4D0E-A42D-266D9857349CQ39990886-0E7489D4-5A33-4E0F-8FB8-CF25B09E1467Q40598889-31419659-1D3B-4A4A-839E-C0ECE6319FCDQ41007598-6F61054F-E599-43D7-B68E-8EC3B167A16CQ41481828-FFC3DF2B-DD7C-4AB8-B049-328888BCF19DQ41901316-EA71E770-23EA-4B48-B266-F872BDCD68A5Q42722045-3A06039E-EDBF-48E2-9B16-6653AAEAA911Q44198145-31416FBF-1227-4E27-B852-77A6FFFDCC42Q46937313-619F8538-ECF8-4E78-A7A7-34EE2A1EF711Q47173840-F70E7C21-44FF-4C08-A8F0-6CC0AB8E28F6
P2860
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
@ast
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
@en
type
label
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
@ast
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
@en
prefLabel
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
@ast
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
@en
P2093
P2860
P1476
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
@en
P2093
P2860
P304
P356
10.1128/AAC.45.7.2157-2159.2001
P407
P577
2001-07-01T00:00:00Z